A detailed history of Jones Financial Companies Lllp transactions in Glaukos Corp stock. As of the latest transaction made, Jones Financial Companies Lllp holds 137 shares of GKOS stock, worth $18,990. This represents 0.0% of its overall portfolio holdings.

Number of Shares
137
Previous 100 37.0%
Holding current value
$18,990
Previous $11,000 54.55%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$113.62 - $135.39 $4,203 - $5,009
37 Added 37.0%
137 $17,000
Q2 2024

Aug 14, 2024

BUY
$89.48 - $118.35 $8,948 - $11,835
100 New
100 $11,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.6B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Jones Financial Companies Lllp Portfolio

Follow Jones Financial Companies Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jones Financial Companies Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Jones Financial Companies Lllp with notifications on news.